Nancy A. Risebrough
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK.
Journal: International journal of chronic obstructive pulmonary disease
Published: June 27, 2024
The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada - The IMPACT trial.
Journal: Respiratory medicine
Published: October 13, 2023
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis.
Journal: Advances in therapy
Published: April 22, 2022
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial.
Journal: International journal of chronic obstructive pulmonary disease
Published: April 12, 2022
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial.
Journal: International journal of chronic obstructive pulmonary disease
Published: October 02, 2021
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model.
Journal: International journal of chronic obstructive pulmonary disease
Published: July 29, 2021
Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial.
Journal: ERJ open research
Published: May 14, 2021
Lifetime Cost-effectiveness of Oral Semaglutide Versus Dulaglutide and Liraglutide in Patients With Type 2 Diabetes Inadequately Controlled With Oral Antidiabetics.
Journal: Clinical therapeutics
Published: March 11, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial.
Journal: Current oncology (Toronto, Ont.)
Published: January 14, 2021
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK.
Journal: ERJ open research
Published: July 08, 2020
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial.
Journal: International journal of chronic obstructive pulmonary disease
Published: May 17, 2019
Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Journal: Respiratory research
Published: January 16, 2019
Last Updated: 09/26/2026